Longitudinal changes in brain metabolites following pediatric concussion

Area of Science:

• Neuroscience
• Pediatric Medicine
• Biomarkers

Background:

• Concussion involves neurometabolic changes, but longitudinal studies in pediatric populations are limited.
• Magnetic Resonance Spectroscopy (MRS) offers non-invasive quantification of brain metabolites.
• Few studies have linked neurometabolite changes to symptom burden in pediatric concussion.

Purpose of the Study:

• To investigate longitudinal neurometabolite changes in pediatric concussion.
• To explore associations between neurometabolites and symptom severity (somatic and cognitive).
• To compare neurometabolite trajectories between concussion and orthopedic injury groups.

Main Methods:

• Recruited pediatric participants with concussion or orthopedic injury (OI).
• Collected MRS data at baseline (mean 12 days post-injury) and follow-up (3 or 6 months).
• Utilized parent-reported symptom questionnaires to assess somatic and cognitive symptoms.

Main Results:

• No significant longitudinal changes in overall neurometabolites were observed in the concussion group.
• Neurometabolite trajectories did not differ between asymptomatic concussion, symptomatic concussion, and OI groups.
• Lower Choline levels at 3 months post-injury were associated with persistent somatic symptoms compared to OI controls.

Conclusions:

• While overall neurometabolites remain stable over time post-pediatric concussion, specific metabolites like Choline may show alterations related to symptom burden.
• Choline levels at 3 months appear to be a potential indicator of persistent somatic symptoms in pediatric concussion.
• Further research is needed to understand the clinical implications of these Choline changes.